TMDX · Transmedics Group Inc
United States · RS rating 22 · As of 2026-11-03
| Price | 67.34 USD |
|---|---|
| 1-day change | +1.0% |
| RS rating (overall / 1M / 3M / 12M) | 22 / 23 / 42 / 22 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 30 / 7 / 50 |
| Industry group (rank) | Medical-Products (106) |
| EPS growth Q/Q | +297.0% |
| Sales growth Q/Q | +11.8% |
| Distance from 52-week high | +55.2% |
| Market cap (USD) | $3.9B |